Search research articles
Contact Us
Filters
Showing results (151-160 of 184) with videos related to
Page
of 19
Sort By:
Revue Des Maladies Respiratoires
|
November 8, 2005
[Antithrombotic therapy for venous thromboembolism - report of the 7th Conference of The American College of Chest Physicians]
A Achkar, M-H Horellou, F Parent, et al.
Annales De Biologie Clinique
|
October 17, 2001
[Influence of oral anticoagulant treatment on D-dimers levels]
E Ombandza-Moussa, M M Samama, M H Horellou, et al.
Thrombosis and Haemostasis
|
October 18, 1993
Haemostatic variables and menopausal status: influence of hormone replacement therapy
P Y Scarabin, G Plu-Bureau, L Bara, et al.
La Revue De Medecine Interne
|
January 1, 1997
[Severe hemorrhagic complications during treatment with low molecular weight heparin. Apropos of 2 cases]
G Grateau, L Chauvenet, S Oudard, et al.
Thrombosis Research
|
April 23, 2003
Comparative study of the pharmacokinetic profiles of two LMWHs--bemiparin (3500 IU, anti-Xa) and tinzaparin (4500 IU, anti-Xa)--administered subcutaneously to healthy male volunteers
F Depasse, M J González de Suso, I Lagoutte, et al.
Seminars in Thrombosis and Hemostasis
|
April 1, 1987
Specific determination and identification of cross-linked fibrin degradation products in patients under thrombolytic therapy for myocardial infarction
J Soria, C Soria, M Mirshahi, et al.
Platelets
|
November 4, 2010
Original Article: Streptokinase Modifies in Vitro Platelet Aggregation by Two Mechanisms: Reduced Aggregation due to Fibrinogenolysis and Enhanced Aggregation via an Immunological Reaction
M Abdelouahed, I Elalamy, J Lebrazi, et al.
Circulation
|
March 1, 1992
In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis
I Gouin, T Lecompte, M C Morel, et al.
Thrombosis and Haemostasis
|
May 29, 1999
Prevention of deep vein thrombosis after hip replacement--comparison between two low-molecular heparins, tinzaparin and enoxaparin
A Planès, M M Samama, A W Lensing, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
October 31, 2001
The role of platelet factor 4 in platelet aggregation induced by the antibodies implicated in heparin-induced thrombocytopenia
G T Gerotziafas, I Elalamy, C Lecrubier, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 184) with videos related to
Sort By:
Page
of 19
Revue Des Maladies Respiratoires
|
November 8, 2005
[Antithrombotic therapy for venous thromboembolism - report of the 7th Conference of The American College of Chest Physicians]
A Achkar, M-H Horellou, F Parent, et al.
Annales De Biologie Clinique
|
October 17, 2001
[Influence of oral anticoagulant treatment on D-dimers levels]
E Ombandza-Moussa, M M Samama, M H Horellou, et al.
Thrombosis and Haemostasis
|
October 18, 1993
Haemostatic variables and menopausal status: influence of hormone replacement therapy
P Y Scarabin, G Plu-Bureau, L Bara, et al.
La Revue De Medecine Interne
|
January 1, 1997
[Severe hemorrhagic complications during treatment with low molecular weight heparin. Apropos of 2 cases]
G Grateau, L Chauvenet, S Oudard, et al.
Thrombosis Research
|
April 23, 2003
Comparative study of the pharmacokinetic profiles of two LMWHs--bemiparin (3500 IU, anti-Xa) and tinzaparin (4500 IU, anti-Xa)--administered subcutaneously to healthy male volunteers
F Depasse, M J González de Suso, I Lagoutte, et al.
Seminars in Thrombosis and Hemostasis
|
April 1, 1987
Specific determination and identification of cross-linked fibrin degradation products in patients under thrombolytic therapy for myocardial infarction
J Soria, C Soria, M Mirshahi, et al.
Platelets
|
November 4, 2010
Original Article: Streptokinase Modifies in Vitro Platelet Aggregation by Two Mechanisms: Reduced Aggregation due to Fibrinogenolysis and Enhanced Aggregation via an Immunological Reaction
M Abdelouahed, I Elalamy, J Lebrazi, et al.
Circulation
|
March 1, 1992
In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis
I Gouin, T Lecompte, M C Morel, et al.
Thrombosis and Haemostasis
|
May 29, 1999
Prevention of deep vein thrombosis after hip replacement--comparison between two low-molecular heparins, tinzaparin and enoxaparin
A Planès, M M Samama, A W Lensing, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
October 31, 2001
The role of platelet factor 4 in platelet aggregation induced by the antibodies implicated in heparin-induced thrombocytopenia
G T Gerotziafas, I Elalamy, C Lecrubier, et al.
Page
of 19